Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

555
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
555
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

232
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
232
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.7K
Polygenic Traits01:18

Polygenic Traits

66.1K
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
66.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repurposing trazodone for Alzheimer's disease to modulate soluble ST2 levels and alleviate Alzheimer's pathology.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Site-specific trastuzumab Fab-DM1 via butelase-1 with ABD fusion for potent HER2-positive tumor control.

Medical oncology (Northwood, London, England)·2026
Same author

Dominant Controlling Factors and Displacement Performance in Heavy Oil Recovery Processes.

ACS omega·2026
Same author

Cold Stress Activates ACSL1+ Macrophages in a Fatty Acid-Dependent Manner to Exacerbate Psoriasis.

Experimental dermatology·2026
Same author

Activated PIK3CD drives marginal zone B cell development from early transitional progenitors by enhancing ADAM10 expression.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same author

KCMF1 promotes MASLD progression via K48-linked ubiquitination and degradation of AMPKα.

Metabolism: clinical and experimental·2026

Related Experiment Video

Updated: Aug 4, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K

Deep learning-based polygenic risk analysis for Alzheimer's disease prediction.

Xiaopu Zhou1,2,3, Yu Chen1,3,4, Fanny C F Ip1,2,3

  • 1Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China.

Communications Medicine
|April 6, 2023
PubMed
Summary

Deep learning models significantly improve Alzheimer's disease (AD) risk prediction by capturing complex genetic interactions. These advanced models offer better insights into disease mechanisms and individual risk stratification compared to traditional methods.

More Related Videos

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.0K
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.0K

Related Experiment Videos

Last Updated: Aug 4, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.0K
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.0K

Area of Science:

  • Genetics
  • Computational Biology
  • Neuroscience

Background:

  • Alzheimer's disease (AD) is polygenic, meaning multiple genetic variants contribute to susceptibility.
  • Current statistical methods struggle to fully capture complex polygenic risk for AD, limiting prediction accuracy.
  • Deep learning offers potential for more accurate AD risk prediction by modeling nonlinear relationships in high-dimensional genomic data.

Purpose of the Study:

  • To develop and evaluate deep learning neural network models for modeling Alzheimer's disease (AD) polygenic risk.
  • To compare the performance of deep learning models against traditional statistical approaches for AD risk prediction.
  • To explore the utility of deep learning in uncovering AD etiology and identifying distinct pathological mechanisms.

Main Methods:

  • Construction of neural network models to assess AD polygenic risk.
  • Comparison of deep learning models with weighted polygenic risk score and lasso models.
  • Robust linear regression to analyze the association between deep learning-derived polygenic risk and AD endophenotypes (plasma biomarkers, cognitive performance).
  • Unsupervised clustering applied to neural network hidden layer outputs for individual stratification.

Main Results:

  • Deep learning models demonstrated superior performance in modeling AD risk compared to conventional statistical models.
  • The polygenic risk scores derived from deep learning facilitated the identification of AD-associated biological pathways.
  • Deep learning enabled effective stratification of individuals based on distinct pathological mechanisms.

Conclusions:

  • Deep learning methods are highly effective for modeling and classifying genetic risks in Alzheimer's disease (AD).
  • These methods enhance our understanding of AD etiology by uncovering disease-specific mechanisms.
  • Deep learning holds promise for improving risk prediction and stratification in AD and other complex diseases.